KeyBanc analyst Matthew Mishan maintained a Buy rating on Cooper Companies on Tuesday, setting a price target of $425, which is approximately 8.57% above the present share price of $391.44.
Mishan expects Cooper Companies to post earnings per share (EPS) of $1.65 for the first quarter of 2021.
The current consensus among 6 TipRanks analysts is for a Moderate Buy rating of shares in Cooper Co (NYSE:COO), with an average price target of $403.4.
The analysts price targets range from a high of $445 to a low of $355.
In its latest earnings report, released on 10/31/2020, the company reported a quarterly revenue of $681.6 million and a net profit of $100.1 million. The company's market cap is $19.24 billion.
According to TipRanks.com, KeyBanc analyst Matthew Mishan is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 12.0% and a 71.72% success rate.
The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers. The Cooper Surgical business unit focuses on supplying women's health clinicians with market medical products and treatment options to improve the delivery of healthcare to women. The company was founded in 1958 and is headquartered in San Ramon, CA.